NEW YORK--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq:DCTH) announced today that the Company’s high dose percutaneous perfusion technology for delivery of
For more information, please visit
http://home.businesswire.com/portal/site[...]sId=20071018005737&newsLang=en